Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-02-2018 | Letter to the Editor

All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting

Authors: Sally F. Barrington, Tom Sulkin, Adam Forbes, Peter W. M. Johnson

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2018

Excerpt

Dear Sir, …

Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma. 2009;50:1257–60.CrossRefPubMed

Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44:17–31.CrossRefPubMedPubMedCentral

Q.Clear - PET/CT Applications - PET/CT - Molecular Imaging - Nuclear Medicine\PET-CT\PET-Radiopharmacy - Products. Accessed 10/25/2017 2017.

Johnson P, Federico M, Fossa A, O'Doherty M, Roberts T, Stevens L, et al. Response-adapted therapy based on interim FDG-PET scans in advanced Hodgkin lymphoma first analysis of the safety of de-escalation and efficacy of escalation in the international RATHL study (CRUK/07/033). Hematol Oncol. 2015;33:100–80.CrossRef

mi_emea_sharpir_white_paper_pdf_092010_doc0852276.pdf. Accessed 10/25/2017 2017.

Panin VY, Kehren F, Michel C, Casey M. Fully 3-D PET reconstruction with system matrix derived from point source measurements. IEEE Trans Med Imaging. 2006;25:907–21.CrossRefPubMed

van der Vos CS, Koopman D, Rijnsdorp S, Arends AJ, Boellaard R, van Dalen JA, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging. 2017;44:4–16.CrossRefPubMedPubMedCentral

Alessio AM, Stearns CW, Tong S, Ross SG, Kohlmyer S, Ganin A, et al. Application and evaluation of a measured spatially variant system model for PET image reconstruction. IEEE Trans Med Imaging. 2010;29:938–49.CrossRefPubMedPubMedCentral

Bettinardi V, Presotto L, Rapisarda E, Picchio M, Gianolli L, Gilardi MC. Physical performance of the new hybrid PETCT Discovery-690. Med Phys. 2011;38:5394–411.CrossRefPubMed

10.

Teoh EJ, McGowan DR, Bradley KM, Belcher E, Black E, Gleeson FV. Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules. Eur Radiol. 2016;26:576–84.CrossRefPubMed

11.

Teoh EJ, McGowan DR, Bradley KM, Belcher E, Black E, Moore A, et al. 18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction. Eur Radiol. 2016;26:4098–106.CrossRefPubMedPubMedCentral

12.

Parvizi N, Franklin JM, McGowan DR, Teoh EJ, Bradley KM, Gleeson FV. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases? Eur J Radiol. 2015;84:1873–8.CrossRefPubMed

13.

Kuhnert G, Boellaard R, Sterzer S, Kahraman D, Scheffler M, Wolf J, et al. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Eur J Nucl Med Mol Imaging. 2016;43:249–58.CrossRefPubMed

14.

Quak E, Le Roux PY, Lasnon C, Robin P, Hofman MS, Bourhis D, Callahan J, Binns DS, Desmonts C, Salaun PY, Hicks RJ, Aide N. Does PET SUV Harmonization affect PERCIST response classification?. J Nucl Med 2016;57:1699–1706.

15.

Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–68.CrossRefPubMedPubMedCentral

16.

Andre MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, et al. Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol. 2017;35:1786–94.CrossRefPubMed

17.

Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, et al. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet. 2012;379:1791–9.CrossRefPubMed

18.

Radford J, Illidge T, Counsell N, Hancock B, Pettengell R, Johnson P, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. N Engl J Med. 2015;372:1598–607.CrossRefPubMed

19.

EQPET_WP.indd - eq-pet_wp-02580275.pdf. Accessed 11/10/2017 2017.

Title: All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting
Authors: Sally F. Barrington
Tom Sulkin
Adam Forbes
Peter W. M. Johnson
Publication date: 01-02-2018
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-017-3893-z

At a glance: The STEP trials

Springer Medicine

All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2018

Invited editorial for the paper by Silvoniemi et al. “Repeatability of tumor hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer.” in this issue of EJNMMI

68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans

Patterns of bone tracer uptake on SPECT-CT in symptomatic and asymptomatic patients with primary total hip arthroplasty

Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis

Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study

The prognostic value of 18F–FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases